CureDuchenne Ventures invests in Entos Pharmaceuticals to support the development of a muscle-targeting therapeutic for Duchenne muscular dystrophy (DMD). The funding amount was not disclosed.
Round Type
Funding Round
Investors
Description
Entos Pharmaceuticals, an Edmonton-based biotech company, received an investment from CureDuchenne Ventures. The company plans to use the funds to develop a therapeutic aimed at delivering full-length dystrophin. This initiative targets the treatment of Duchenne muscular dystrophy (DMD). Entos utilizes its innovative Fusogenix PLV platform for genetic medicine delivery.
Quick answer
Entos Pharmaceuticals raised an undisclosed amount in a Funding Round round, dated May 22, 2025. Investors: CureDuchenne Ventures.
- How much did Entos Pharmaceuticals raise?
- Entos Pharmaceuticals raised an undisclosed amount in a Funding Round round on May 22, 2025.
- Who invested in Entos Pharmaceuticals?
- CureDuchenne Ventures is named as investors in this round.
- What does Entos Pharmaceuticals do?
- Entos Pharmaceuticals is a clinical-stage genetic medicines company focused on developing cures and improving patients' lives using its proprietary Fusogenix™ PLV™ technology.
- Where is Entos Pharmaceuticals based and how big is it?
- Fundz records about 44 employees.
- Who are the decision-makers at Entos Pharmaceuticals?
- Fundz holds 1 contact at Entos Pharmaceuticals. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Genetics and Therapeutics around the same time
Companies in the same sectors as Entos Pharmaceuticals that raised within 45 days of this round, from Fundz verified event records.
- VolitionRx raised $16M on May 20, 2025.
- Pelthos Therapeutics raised $50M on July 1, 2025.
- FELIQS raised $9M (Series A) on July 1, 2025.
- Gallant raised $18M (Series B) on June 30, 2025.
- NewcelX raised $1M (Seed) on June 27, 2025.
- Gallant raised $10M on June 27, 2025.
Who to call at Entos Pharmaceuticals, and when
A new round usually means Entos Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Entos Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Entos Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Entos Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Entos Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Entos Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.